3NUM is a Web3 Sheild Messaging NFT that protects the identity and provides private, secure messaging.

Agnostic develops a blockchain data cloud platform. The company platform is an app development and analytics technology that helps businesses bring proper blockchain data to customers, DevOps, and executives.

Airtm is an e-wallet connected to over 300 bank and e-money systems via a peer-to-peer network and direct bank connections. Users hold their money as dollars or cryptocurrency, and can send and receive funds domestically and internationally. Airtm was founded in 2015 with the goal of leveraging digital money to help people in the developing world suffering from currency devaluation preserve their wealth and free their money from disconnected money networks. Headquartered in Mexico City and San Francisco, Airtm is a US-registered money service business.

Developer of healthcare tools designed to amplify health diagnostics. The company combines thermal image technology and computer vision to create a standardized and objective assessment for diabetic foot ulcers enhance efficiency in foot assessments, and ensure care, helping patients improve outcomes through precise early detection.

Creating the radio platform for integrated sensing and communications.

Biofidelity developed a revolutionary molecular diagnostic assay that enables the rapid detection of target DNA sequences. Biofidelity’s mission is to improve and extend patients’ lives by enabling early detection of disease and better targeting of treatments with applications spanning oncology, prenatal testing, infectious disease, and organ transplant monitoring. Biofidelity was founded in 2019 and is headquartered of Cambridge, England.

Biomia is a synthetic biology company developing plant-derived natural products for unmet medical needs in pain, addiction, and depression.

Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell. Their mission is coding cells for health. To do so, we apply the principles of computation to biology. Bit.bio's current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell. This has the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by the human disease. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies. To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modeling, and cell therapy. Collaboration is at the heart of bit.bio. We are empirical, highly ambitious, and driven by a common purpose.

Castelion is bringing a new approach to defense development and production: one that focuses on short, iterative design cycles, rapid testing in development, and modern commercial manufacturing strategies for production at scale. We’re designing, building, and testing next generation long range strike weapons systems to give America and its Allies a definitive edge and deter future conflicts.

Founded in 2017, Centrifuge creates better technology for financial products. Centrifuge provides asset managers a way to tokenize, manage and distribute their funds onchain and investors better access to a diversified portfolio of high-quality tokenized assets.

Digitising Chemistry and Chemical Discovery

Clock Bio operates as a biotech company, that develops novel regenerative medicines.